EUROAPI acquires BianoGMP to strengthen expertise in burgeoning oligonucleotide market 07-Sep-2023 By Isabel Cameron EUROAPI and BianoGMP have signed a share purchase and transfer agreement under which EUROAPI will acquire 100% of Biano’s shares.
LNPs as drug delivery platforms: Overcoming bioanalytical hurdles 16-Feb-2022 By Jane Byrne Lipid nanoparticle systems (LNPs) as a delivery mechanism for novel drug modalities are proving effective, but there are bioanalytical challenges associated with encapsulation, says an expert.